GLP-1 is a hormone that regulates blood sugar, appetite and digestion. A diet rich in high-fiber foods may help your body ...

Hims & Hers will begin offering generic semaglutide drugs in Canada next year after Novo Nordisk lost its exclusive patent ...

Tatiana De La Rosa is leaving carb-cutting behind (and scaling back her love of tequila) on compounded tirzepatide.

An Ozempic user has revealed one unexpected side effect that's 'causing issues in their relationship'. While many people are having a lot of success taking GLP-1 drugs such as Ozempic, Mounjaro and ...

Viking Therapeutics's obesity/diabetes candidates and strong financials position it for success. Read here for an investment ...

In the coming years, the mismatch of revenue growth and expense growth for providers of health care will result in ...

The United States diabetes drugs market size is projected to exhibit a growth rate (CAGR) of 3.55% during 2025-2033. The ...

The weight-loss drug boom has dominated headlines for the last two years — but underneath the hype lies a major flaw in the ...

Objective Phase II trials suggest glucagon-like peptide-1 receptor (GLP1) agonists resolve metabolic dysfunction-associated steatohepatitis but do not affect fibrosis regression. We aimed to determine ...

GoodRx Holdings leverages its patented screening technology to find prescription coupons for uninsured or underinsured ...

Both well-established and small, clinical-stage pharma companies are investing heavily to be able to someday compete with ...

MariTide helped participants lose up to 20% of their body weight in a year-long trial. But it could be years before the new ...